Skip to main content
. 2022 Jan 5;28(3):422–434. doi: 10.1111/cns.13791

FIGURE 5.

FIGURE 5

Liraglutide administration inhibited pyroptosis‐related NLR Family, pyrin domain‐containing protein 3 (NLRP3) signaling pathway (n ≥ 3 per group). * represents p < 0.05, ** represents p < 0.01, *** represents p < 0.001. Data were shown in the form of mean ± SEM. (A–D) shows result of key pyroptosis indicators mRNA expression level. (E–H) shows result of key pyroptosis indicators protein expression level